Two types of leptin-responsive gastric vagal afferent terminals: an in vitro single-unit study in rats.
In vitro gastric vagal afferents' (GVAs) unit activities were recorded from the ventral GVA nerve strands in rats. The responsiveness of 16 GVA terminals to close intra-arterial injection of vehicle (0.1 ml), leptin (350 pmol), and cholecystokinin (CCK)-8 (10 pmol) was analyzed to generate a spike count-versus-time histogram. Data of 5-min spike counts before and after each treatment were normalized by dividing the latter by the former. A quotient (Q) > 1 indicates an excitatory effect, Q < 1 indicates an inhibitory effect, and Q close to 1 indicates no effect. Two types of GVA terminals were identified. Type 1 (n = 8) responded to leptin with Q > 1; CCK-8 pretreatment did not consistently alter leptin sensitivity. In contrast, Type 2 (n = 8) responded to leptin with Q < 1 or close to 1, and CCK-8 pretreatment increased the leptin sensitivity so that the terminals responded to subsequent leptin with Q > 1. These data suggest that Type 1 and Type 2 GVA terminals may provide afferent neural signals, which, in turn, will be involved in body weight and food intake control systems, respectively.
Wang
Y H
YH
Center for Ulcer Research and Education/Digestive Diseases Research Center, Los Angeles, California, USA.
Taché
Y
Y
Sheibel
A B
AB
Go
V L
VL
Wei
J Y
JY
D000818:Animals; D007269:Injections, Intra-Arterial; D020738:Leptin; D008297:Male; D008465:Mechanoreceptors / Q000187:drug effects; D009411:Nerve Endings / Q000187:drug effects*; D009475:Neurons, Afferent / Q000187:drug effects*; D014677:Pharmaceutical Vehicles; D011506:Proteins / Q000494:pharmacology*; D051381:Rats; D012844:Sincalide / Q000494:pharmacology; D013270:Stomach / Q000294:innervation*; D014630:Vagus Nerve / Q000166:cytology / Q000187:drug effects*
D020738:Leptin; D014677:Pharmaceutical Vehicles; D011506:Proteins; D012844:Sincalide